US HB6400 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on November 14 2023 - 25% progression, died in committee
Action: 2023-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 14 2023 - 25% progression, died in committee
Action: 2023-11-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.
Title
To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.
Sponsors
Rep. Tony Cardenas [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2023-11-17 | House | Referred to the Subcommittee on Health. |
2023-11-14 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2023-11-14 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/6400/all-info |
Text | https://www.congress.gov/118/bills/hr6400/BILLS-118hr6400ih.pdf |